Your browser doesn't support javascript.
loading
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
Jeffery-Smith, Anna; Rowland, Thomas A J; Patel, Monika; Whitaker, Heather; Iyanger, Nalini; Williams, Sarah V; Giddings, Rebecca; Thompson, Leah; Zavala, Maria; Aiano, Felicity; Ellis, Joanna; Lackenby, Angie; Höschler, Katja; Brown, Kevin; Ramsay, Mary E; Gopal, Robin; Chow, J Yimmy; Ladhani, Shamez N; Zambon, Maria.
Afiliação
  • Jeffery-Smith A; Virus Reference Department, Public Health England, London, UK.
  • Rowland TAJ; Blizard Institute, Queen Mary University of London, London, UK.
  • Patel M; Virus Reference Department, Public Health England, London, UK.
  • Whitaker H; Virus Reference Department, Public Health England, London, UK.
  • Iyanger N; Data and Analytical Sciences, Public Health England, London, UK.
  • Williams SV; London Coronavirus Response Cell, National Infection Service, Public Health England, London, UK.
  • Giddings R; London Coronavirus Response Cell, National Infection Service, Public Health England, London, UK.
  • Thompson L; London Coronavirus Response Cell, National Infection Service, Public Health England, London, UK.
  • Zavala M; London Coronavirus Response Cell, National Infection Service, Public Health England, London, UK.
  • Aiano F; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Ellis J; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Lackenby A; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Höschler K; Virus Reference Department, Public Health England, London, UK.
  • Brown K; Virus Reference Department, Public Health England, London, UK.
  • Ramsay ME; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Gopal R; Immunisation and Countermeasures Division, Public Health England, London, UK.
  • Chow JY; Virus Reference Department, Public Health England, London, UK.
  • Ladhani SN; London Coronavirus Response Cell, National Infection Service, Public Health England, London, UK.
  • Zambon M; Immunisation and Countermeasures Division, Public Health England, London, UK.
Lancet Healthy Longev ; 2(12): e811-e819, 2021 12.
Article em En | MEDLINE | ID: mdl-34873592
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Lancet Healthy Longev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Lancet Healthy Longev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido